Short answer
Yes. Regular use of concentrated 7-OH products may lead to physical dependence and withdrawal in some people.
Typical pattern, based on case reports, clinical experience, and opioid-like pharmacology:
- Onset: often within 6 to 24 hours after the last dose.
- Peak: commonly days 1 to 3.
- Acute physical improvement: often over 7 to 14 days.
- Lingering symptoms: sleep, mood, energy, and cravings may take weeks or longer to settle.
The published literature specifically on concentrated 7-OH withdrawal is still small and mostly case-based. Broader kratom/buprenorphine literature is larger, but kratom leaf and concentrated 7-OH products should not be treated as identical.
Symptoms
What 7-OH withdrawal feels like.
Because 7-OH has opioid-receptor activity, withdrawal may resemble opioid withdrawal and, in some patients, may feel more opioid-like than withdrawal from traditional kratom leaf.
Physical symptoms may include:
- Muscle and joint aches.
- Restless legs or restless arms.
- Sweating, chills, or gooseflesh.
- Runny nose, watery eyes, or yawning.
- Nausea, vomiting, diarrhea, or abdominal cramping.
- Insomnia.
- Fatigue and low energy.
Psychological symptoms may include:
- Anxiety or irritability.
- Low mood.
- Cravings.
- Difficulty concentrating.
- Reduced pleasure from normal activities.
Standard opioid withdrawal scales such as COWS or SOWS may be useful, but they were not designed specifically for 7-OH. A direct conversation about dose, product, timing, and symptoms is often more useful than the score alone.
Timeline
How long does 7-OH withdrawal last?
This table should not be read as a guarantee. Product strength, frequency of dosing, duration of use, other substances, medical conditions, and prior opioid exposure can all change the timeline.
Brain chemistry
Why does the mood get so bad during 7-OH withdrawal?
Mostly three brain chemicals, and each one explains a different piece of the bad mood.
Dopamine — the motivation and reward chemical
Opioids like 7-OH crank up dopamine, so your brain dials its own down. When the 7-OH leaves, you’re low on dopamine — which is why nothing feels rewarding or worth doing. That’s the flat, can’t-enjoy-anything feeling.
Endorphins — the body’s own comfort chemicals
Endorphins are your body’s natural opioids. 7-OH was doing their job, so your brain slowed making them. Without 7-OH you’re low on your own comfort chemicals, so you feel raw, achy, and emotionally tender.
Noradrenaline — the alarm and stress chemical
This one swings the other way during withdrawal and surges too high. That’s the anxiety, restlessness, irritability, and on-edge feeling.
It’s a double hit: too little of the calming, feel-good chemicals (dopamine, endorphins) and too much of the stress chemical (noradrenaline). Both directions push toward a bad mood.
Some people also notice serotonin feeling off — it shapes overall mood and sleep — but the three above are the main drivers in opioid-type withdrawal.
The good news: these reset on their own with time. The brain rebalances once it’s no longer counting on the 7-OH.
Why it differs
Why 7-OH withdrawal differs from kratom leaf withdrawal.
FDA describes 7-OH as occurring naturally in trace amounts in kratom. FDA’s warning focuses on products with added or enhanced 7-OH levels, including tablets, gummies, drink mixes, shots, and other products sold online, in smoke shops, gas stations, and corner stores.
Natural kratom leaf contains a mixture of alkaloids. Concentrated 7-OH products may produce a more pronounced opioid-like effect profile than traditional kratom leaf products. That may contribute to withdrawal symptoms that some people describe as more intense or more difficult to manage.
Preclinical and in-vitro studies have reported that 7-OH may be substantially more potent than mitragynine and, in some assay contexts, more potent than morphine. FDA has described 7-OH as an opioid product that may be more potent than morphine in certain contexts. These findings are based largely on laboratory, preclinical, and regulatory data and should not be interpreted as direct human dose conversions.
Is it dangerous?
Is 7-OH withdrawal dangerous?
For many otherwise healthy, nonpregnant adults, opioid-like withdrawal from 7-OH is not generally considered medically dangerous by itself in the same way alcohol withdrawal or high-dose benzodiazepine withdrawal can be. But it can be very uncomfortable, and the discomfort may increase the risk of return to use, especially without a plan or support.
Important exceptions:
- Severe dehydration from vomiting or diarrhea can require medical care.
- Alcohol, benzodiazepines, opioids, gabapentin, pregabalin, or other sedatives can change the risk picture.
- Pregnancy requires specialized care. Pregnant patients should not abruptly stop opioid-like substances without guidance from clinicians who manage pregnancy and substance use.
- Severe depression, psychosis, or suicidal thinking needs urgent assessment.
- Serious underlying medical illness can complicate withdrawal.
Treatment options
Treatment options for 7-OH withdrawal.
1. Gradual reduction
A gradual reduction may reduce withdrawal intensity. This is often easier with measurable kratom leaf than with concentrated 7-OH products, because 7-OH tablets, shots, and gummies may be harder to divide accurately and may vary by product or batch.
A gradual reduction may not be enough by itself if symptoms become severe, dosing has escalated quickly, or prior attempts to reduce or stop have not been successful.
2. Abrupt discontinuation
Abrupt discontinuation is possible, but it can be difficult. Symptoms may intensify around days 2 to 3, and 7-OH products may be easy to buy nearby or online. Planning matters: remove products from the home, arrange support, hydrate, protect sleep as much as possible, and have a specific plan for the first several days.
Not everyone stopping 7-OH needs medication. Some people recover with gradual reduction and supportive care alone. Others may benefit from medications such as buprenorphine depending on their symptoms, goals, product use, medical history, and prior attempts to stop.
3. Buprenorphine treatment
Buprenorphine, including buprenorphine/naloxone, has been used clinically for kratom withdrawal and has emerging case-based use for concentrated 7-OH withdrawal. It binds tightly to the mu-opioid receptor and may help reduce opioid-like withdrawal symptoms and cravings in selected patients.
This is off-label use. No randomized clinical trials have specifically studied buprenorphine for concentrated 7-OH withdrawal. Published evidence includes case reports and case series, plus broader expert clinical experience. Buprenorphine should be considered case by case, not treated as the standard answer for every 7-OH patient.
Timing matters. Starting buprenorphine before sufficient withdrawal has developed may increase the risk of precipitated withdrawal in some patients. Clinicians may wait for objective withdrawal before starting, or may use a low-dose initiation strategy in selected cases.
Published clinical case · ASAM Annual Conference 2026
At the 57th American Society of Addiction Medicine (ASAM) Annual Conference in 2026, researchers at the University of Miami presented a case of buprenorphine microinduction used for medically managed withdrawal from concentrated 7-hydroxymitragynine (7-OH). The patient had been using 30–50 mg of 7-OH daily for two years. Buprenorphine microinduction was initiated on Day 1, titrated to a total daily dose of 12 mg, and the patient was discharged on Day 5 on Suboxone (buprenorphine 4 mg / naloxone 1 mg three times daily). At follow-up, the patient reported continued control of cravings with residual anxiety symptoms, and pursued psychotherapy.
Mulloy K, Nawab A, Patel D. Successful Buprenorphine Microinduction in Patient With Severe Kratom (7-OH) Use Disorder. American Society of Addiction Medicine 57th Annual Conference, 2026.
How to get off 7-OH
How to get off 7-OH.
There is no single best plan for stopping 7-OH. The right approach depends on daily dose, product type, how long use has continued, prior attempts to reduce or stop, other substances, mental health, pregnancy, and other medical conditions. Three approaches are commonly discussed, and they are described in more detail in the section above. In short:
- Gradual reduction. Some plans gradually reduce the daily dose over days to weeks. This is often easier with measurable kratom leaf than with concentrated 7-OH tablets, shots, or gummies, which can be hard to divide accurately and may vary by product or batch. A reduction plan may not be enough by itself if symptoms become severe or if prior attempts to reduce or stop have not held.
- Abrupt discontinuation. Stopping all at once is possible, but it can be difficult. Symptoms often intensify around day 2 or day 3, and 7-OH products are often easy to buy nearby or online. Planning matters: remove products from the home, arrange support, hydrate, protect sleep, and have a specific plan for the first several days.
- Buprenorphine treatment. Buprenorphine, including buprenorphine/naloxone (Suboxone), has been used clinically for kratom withdrawal and has emerging case-based use for concentrated 7-OH withdrawal. It binds tightly to the mu-opioid receptor and may help reduce opioid-like withdrawal symptoms and cravings in selected patients. This is off-label use. No randomized clinical trials have specifically studied buprenorphine for concentrated 7-OH withdrawal; published evidence is limited to case reports, case series, and expert clinical discussion. Timing matters: starting buprenorphine too soon after 7-OH may increase the risk of precipitated withdrawal.
The best approach for a given person is a clinical conversation, not a one-size-fits-all answer. People using higher doses, people using concentrated products, people whose prior attempts to reduce or stop have been difficult, and people with other substance use or mental-health conditions may benefit from clinical support.
If you are pregnant or could be pregnant, do not stop 7-OH or other opioid-like substances abruptly without specialized guidance from a clinician experienced in pregnancy and substance-use care. MyStreetHealth does not directly treat pregnant patients.
See the section above for fuller detail on each approach.
How do you get off 7-OH?
There is no single best plan for stopping 7-OH. The right approach depends on daily dose, product type, duration of use, prior attempts to reduce or stop, other substances, mental health, pregnancy, and other medical conditions. Three approaches are common: gradual reduction, stopping all at once with planning and support, and buprenorphine treatment. Buprenorphine may help suppress opioid-like withdrawal symptoms and reduce cravings in selected patients, but this is off-label use for kratom and 7-OH withdrawal. People using higher doses, people using concentrated products, people whose prior attempts to reduce or stop have been difficult, and people with other substance use or mental-health conditions may benefit from clinical support. Pregnant patients should not stop abruptly without specialized guidance.
When to seek help
When to seek help.
Speak with a clinician about 7-OH withdrawal if:
- You are using 7-OH products daily and want help reducing or stopping.
- You cannot get past the first several days after stopping.
- Withdrawal interferes with work, family responsibilities, or safety.
- You are using alcohol, benzodiazepines, opioids, gabapentin, pregabalin, or other sedatives.
- You have severe depression, psychosis, or suicidal thinking.
- You are pregnant or could be pregnant.
- You have liver disease, severe heart disease, seizure history, or another serious medical condition.
Treatment
Treatment for 7-OH and kratom dependence is available online.
MyStreetHealth treats kratom and 7-OH dependence through secure telehealth visits in Virginia, West Virginia, Maryland, Washington DC, Ohio, Florida, North Carolina, Georgia, Pennsylvania, and California. Same-day visits are often available when the schedule permits. No insurance is required.
Medical note
This page is educational and does not replace medical care. Seek urgent medical advice for severe vomiting or dehydration, chest pain, confusion, fainting, seizure, severe sedation, slowed or difficult breathing, suicidal thinking, pregnancy, or use with alcohol, benzodiazepines, opioids, gabapentin, pregabalin, or other sedatives.